Is Pfizer Stock a Buy Now?
Pharmaceutical giant (NYSE: PFE) went through a growth spurt during the COVID-19 pandemic as one of the leading vaccine companies. But the windfall of billions of extra dollars in revenue and profits has gone as quickly as it came.
Today, Pfizer stands roughly where it did before COVID-19 and shares trade at their lowest levels since the initial pandemic market crash in 2020. Is the stock a long-term buy after recently completing a blockbuster $43 billion acquisition?
Here is what investors need to know.
Source Fool.com
Pfizer Inc. Stock
€21.71
0.790%
We see a rather positive sentiment for Pfizer Inc. with 15 Buy predictions and 2 Sell predictions.
As a result the target price of 29 € shows a positive potential of 33.61% compared to the current price of 21.71 € for Pfizer Inc..
